Skip to content

Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy

Feasibility, Safety and Patient Reported Outcomes of 3D-Printed Externally-applied Cranial Orthosis (PEACO) After Decompression Craniectomy in Clinical Settings: A Retrospective Comparison Study of Monitored Versus Unmonitored Protocols

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07122752
Enrollment
32
Registered
2025-08-14
Start date
2025-07-29
Completion date
2026-08-29
Last updated
2025-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Brain Injury, Brain Tumor, Stroke, Traumatic Brain Injury

Keywords

Cranial Orthosis, 3D Printing, Decompression Craniectomy, Retrospective Study, Head Protection Device, Monitored Protocol, Unmonitored Protocol

Brief summary

This study will compare the outcomes of a current clinical implementation of PEACO designed for one-handed donning and doffing with carer-monitoring with a previous prototype (HPPD) requiring carer-donning and doffing with therapist monitoring.

Detailed description

The study aims to: 1. Evaluate the feasibility, safety and clinical outcomes of a 3D-printed externally applied cranial orthosis (PEACO) in a clinical setting (unmonitored protocol) 2. Comparison of device A - 2021 Head Protection Prototype Device (HPPD) (DSRB 2019/00155)-monitored protocol with device B (PEACO).

Interventions

None listed

Sponsors

Tan Tock Seng Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Unilateral decompressive craniectomy (DC) * Acute Stroke or traumatic brain injury * \>30 days post DC * Healed surgical wounds, non-bulging flaps * Presence of caregiver supervision

Exclusion criteria

* Vegetative or minimally responsive state * Uncontrolled medical illnesses, e.g. sepsis, delirium, active malignancy * Life expectancy \< 6 months * Unhealed or infected post-DC neurosurgical wounds * Known allergy to investigational products

Design outcomes

Primary

MeasureTime frameDescription
Treatment-emergent adverse events (safety and tolerability)30 minutes post fitting (version 1 and 2)The therapist will assess patient in terms of pain, redness, skin imprints and pruritus' on patient's skin after wearing the cranial cap. This is to allow the understanding of the incidence of the treatment-emergent adverse events (safety and tolerability).
Patient Reported Outcome Measures (PROMS) PROMs (compliance)2023-2025The patient will be sent a questionnaire. The question relating to compliance is Approximately, how many hours of wear per day including rest breaks? This will allow team to assess feasibility, safety and clinical outcomes.
Patient Reported Outcome Measures (PROMS) PROMs (wearing time)2023-2025The patient will be sent a questionnaire. The question relating to wearing time is Approximately, how many hours of wear per day including rest breaks? This will allow team to assess feasibility, safety and clinical outcomes.
Patient Reported Outcome Measures (PROMS) PROMs (adverse events)2023-2025The patient will be sent a questionnaire. The question relating to adverse event is Did you experience any of the following after two hours of wear? This will allow team to assess feasibility, safety and clinical outcomes.
Patient Reported Outcome Measures (PROMS) PROMs (cosmesis rating)2023-2025The patient will be sent a questionnaire. The question relating to cosmesis rating is Please rate the appearance of your cranial cap. This will allow team to assess feasibility, safety and clinical outcomes.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026